Skip to main content
CLDX logo

CLDX · Celldex Therapeutics, Inc. · Held by Funds

Track CLDX — free
$28.03 +0.48 (+1.72%) Q4 2021 earnings call transcript
Market Cap
$2.16B
Shares
78.55M
Volume · Nov 19 75.61K Avg daily vol (3M) 1.33M

Registered funds — mutual funds, ETFs and closed-end funds — whose latest Form N-PORT portfolio report holds this exact listed security, matched by CUSIP. Each row is one fund position with its size, value and weight in that fund.

Fund Ownership of CLDX by Fund Type

Registered funds' Form N-PORT reports for the quarter ended Jun 30, 2026

Index funds and index ETFs hold 16.05% of shares outstanding.

Fund type Of shares outstanding Shares
Index funds 3.35% 2,632,706
Index ETFs 12.70% 9,972,640
Active ETFs 0.77% 608,289
Active funds 21.45% 16,846,774
Unclassified 0.10% 75,214
All registered funds 38.37% 30,135,623
How fund types are measured

Each fund series counts once, with its latest Form N-PORT report dated inside the quarter; only long share positions count, restated to today's split basis. The fund type is the series' latest Form N-CEN answer on or before the quarter end (the index-fund box and the exchange-traded flag), never its name. Unclassified funds have no usable N-CEN; unit investment trusts are among them, so index ownership is a floor. Funds sit inside their advisers' 13F reports, so these shares overlap the 13F figures and are never added to them.

Funds holding CLDX

256 fund positions
Fund Balance Value % of Fund Open
Showing 1–50 of 256 positions
Key facts CIK 744218 CUSIP 15117B202 13F (30d) 267 filings 239 filers Visit website Investor relations